Invirsa

Columbus, OH · Founded 2014 · Privately Held (backing)

Developer of a therapeutic platform designed to treat infectious and inflammatory eye diseases through activation of innate cellular defense and repair pathways. Invirsa is based in Columbus, OH and was founded in 2014. Its last reported valuation was $38 million in Nov 2023. It has raised $14.3 million across 3 recorded rounds; the latest was a $2.9 million seed round in Jul 2025.

Last reported valuation
$38.0M
Oct 2026
Priced at
—
Total raised
$14.3M
Last round
Seed Round
Jul 2025
How much has Invirsa raised?
$14.3Macross 3 recorded rounds · Dec 2022 – Jul 2025

Most recently, Invirsa raised $2.9M in its Seed Round (Jul 2025).

Free account
More of Invirsa with a free account
  • ·Watch Invirsa: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Invirsa round by round

3 rounds
Jul 2025Seed Round$2.9MSEC filing▮
14 investors participated
Nov 2023Seed Round$1.0MSEC filing▮
1 investors participated
Dec 2022Early Stage VC$6.0MSEC filing▮
8 investors participated

How much has Invirsa raised?

Invirsa has raised $14.3 million across 3 recorded rounds since 2022. The largest was a $1 million seed round in Nov 2023; the most recent was a $2.9 million seed round in Jul 2025.

Invirsa has filed 5 Form Ds with the SEC since 2020, most recently in Aug 2025 ($2.9 million sold to 14 investors).

Invirsa investors

8 investors are on record for Invirsa, including Endless Frontier Labs, Jumpstart Ventures, JobsOhio Ventures and Rev1 Ventures. The seed round in Jul 2025 drew 14 investors.

For fundraisers
Raising for a company like Invirsa?

8 investors have backed Invirsa.

See all 8 investors →

Frequently asked about Invirsa

How much has Invirsa raised?
Invirsa has raised $14.3M in total across 3 recorded funding rounds.
When was Invirsa's last funding round?
Invirsa's most recent recorded round was Seed Round in Jul 2025, raising $2.9M.